These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30615214)

  • 1. Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients.
    Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Mendonça D; Alonso I; Sousa A; Lemos C
    Ann Neurol; 2019 Feb; 85(2):251-258. PubMed ID: 30615214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mtDNA copy number associated with age of onset in familial amyloid polyneuropathy.
    Santos D; Santos MJ; Alves-Ferreira M; Coelho T; Sequeiros J; Alonso I; Oliveira P; Sousa A; Lemos C; Grazina M
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):300-304. PubMed ID: 29018163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
    Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
    Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
    Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
    Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
    Rudolph T; Kurz MW; Farbu E
    Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Dias A; Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Alonso I; Sousa A; Lemos C
    Ann Clin Transl Neurol; 2019 Apr; 6(4):748-754. PubMed ID: 31019999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
    Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
    Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
    Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
    Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis.
    Alves-Ferreira M; Azevedo A; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
    Amyloid; 2021 Jun; 28(2):100-106. PubMed ID: 33461327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
    Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
    J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
    Mariani LL; Lozeron P; Théaudin M; Mincheva Z; Signate A; Ducot B; Algalarrondo V; Denier C; Adam C; Nicolas G; Samuel D; Slama MS; Lacroix C; Misrahi M; Adams D;
    Ann Neurol; 2015 Dec; 78(6):901-16. PubMed ID: 26369527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy.
    Zaros C; Genin E; Hellman U; Saporta MA; Languille L; Wadington-Cruz M; Suhr O; Misrahi M; Planté-Bordeneuve V
    Ann Hum Genet; 2008 Jul; 72(Pt 4):478-84. PubMed ID: 18460047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
    Andrés N; Poza JJ; Martí Massó JF
    Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of familial amyloid polyneuropathy type I in Argentina].
    Pérez G; Romero MC; Trigo P; Lendoire J; Imventarza O; Nesse A
    Medicina (B Aires); 2008; 68(4):273-81. PubMed ID: 18786882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
    Oide T; Arima K; Yamazaki M; Hanyu N; Ikeda S
    Amyloid; 2004 Sep; 11(3):191-9. PubMed ID: 15523922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
    Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
    Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina].
    Chaves M; Bettini M; Marciano S; Sáez S; Cristiano E; Rugiero M
    Medicina (B Aires); 2016; 76(2):105-8. PubMed ID: 27135849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.